IP Library Granted Patent US 8,673,618
Granted Patent B2
US 8,673,618 · App. 12/908,483 · Granted Mar 18, 2014

Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose

Inventors: Alexander V. Gusakov (Moscow, RU); Tatyana N. Salanovich (Moscow, RU); Alexey I. Antonov (Moscow, RU); Boris B. Ustinov (Tula, RU); Oleg N. Okunev (Moscow Region, RU); Richard P. Burlingame (Jupiter, FL); Mark A. Emalfarb (Jupiter, FL); Marco A. Baez (Jupiter, FL); Arkady P. Sinitsyn (Moscow, RU)
Assignee: Dyadic International (USA), Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,618
App. No.
12/908,483
Granted
Mar 18, 2014
Kind
B2
Abstract

This invention provides novel enzyme compositions using newly identified and isolated C. lucknowense enzymes, including CBH Ib CBH IIb, EG II, EG VI, β-glucosidase, and xylanase II in conjunction with previously identified enzymes CBH Ia, CBH IIa (previously described as Endo 43), and EG V. These enzyme compositions demonstrate an extremely high ability to convert lignocellulosic biomass (e.g., Avicel, cotton, Douglas fir wood pretreated by organosolv) to glucose. CBH Ia and IIb, which both have a cellulose-binding module (CBM) displayed a pronounced synergism with three major endoglucanases (EG II, EG V, EG VI) from the same fungus in hydrolysis of cotton as well as a strong synergy with each other. The enzyme compositions are effective in hydrolysis of the lignocellulosic biomass.

Claims (15)

1. A mutant Chrysosporium lucknowense strain capable of expressing at least one cellobiohydrolase and at least one endo-1,4-β-glucanase at higher levels than the corresponding non-mutant strain under the same conditions;

wherein at least one cellobiohydrolase is selected from the group consisting of CBH Ia, CBH Ib, CBH IIa and CBH IIb; and wherein at least one endo-1,4-β-glucanase is selected from the group consisting of EG II, EG V, and EG VI.

2. The mutant Chrysosporium lucknowense strain according to claim 1 , wherein said strain is capable of expressing a β-glucosidase and/or a xylanase at higher levels than the corresponding non-mutant strain under the same conditions.

3. The mutant Chrysosporium lucknowense strain according to claim 2 , wherein said xylanase is Xyl II.

4. The mutant Chrysosporium lucknowense strain according to claim 1 , wherein said mutant is or is derived from a Chrysosporium lucknowense mutant strain selected from the group consisting of Chrysosporium lucknowense strain C1 (Deposited as Accession Number VKM F-3500 D), UV13-6 (Deposited as Accession Number VKM F-3632 D), NG7C-19 (Deposited as Accession Number VKM F-3633 D), and UV18-25 (Deposited as Accession Number VKM F-3631 D).

5. The mutant Chrysosporium lucknowense strain according to claim 1 , wherein at least one of said EG II, EG V, and EG VI one endo-1,4β-glucanases are selected from the group consisting of EG II (SEQ ID NO: 10), EG V (SEQ ID NO: 14), EG VI (SEQ ID NO: 16).

6. The mutant Chrysosporium lucknowense strain according to claim 1 , wherein at least one of said CBH Ia, CBH Ib, CBH IIa and CBH IIb are selected from the group consisting of CBH Ib (SEQ ID NO: 2), CBH IIb (SEQ ID NO: 4), EG II (SEQ ID NO: 10), EG V (SEQ ID NO: 14), EG VI (SEQ ID NO: 16), BGL (SEQ ID NO: 12), and Xyl II (SEQ ID NO: 18).

7. The mutant Chrysosporium lucknowense according to claim 1 , wherein at least one of said cellobiohydrolase and at least one endo-1,4-β-glucanase have at least 65% amino acid identity as determined by the BLAST algorithm with at least one of the following:

EG VI amino acid sequence of SEQ ID NO: 16 or a part thereof having at least 20 contiguous amino acids;

the BGL amino acid sequence of SEQ ID NO: 12 or a part thereof having at least 20 contiguous amino acids;

the Xyl II amino acid sequence of SEQ ID NO: 18 or a part thereof having at least 20 contiguous amino acids.

8. A modified microorganism or plant capable of expressing one or more of an enzyme selected from the group consisting of CBH Ib (SEQ ID NO: 2), CBH IIb (SEQ ID NO: 4), EG II (SEQ ID NO: 10), EG V (SEQ ID NO: 14), EG VI (SEQ ID NO: 16), BGL (SEQ ID NO: 12), and Xyl II (SEQ ID NO: 18) and the second enzyme is a hemicellulase, cellobiohydrolase, endo-1,4-βglucanase, β-glucosidase or a xylanase.

9. The modified microorganism according to claim 8 , wherein said microorganism is a fungus.

10. The modified microorganism according to claim 9 , wherein said fungus is selected from the group consisting of Talaromyces, Aspergillus, Trichoderma, Neurospora, Penicillium, Fusarium, Humicola, Myceliophthora, Corynascus, Chaetomium, Tolypocladium, Thielavia, Acremonium, Sporotrichum, Thermoascus, and Chrysosporium.

11. The modified microorganism according to claim 10 , wherein said fungus of the genus Chrysosporium is a strain selected from the group consisting of the wild-type Chrysosporium strain C1 , Deposited as Accession Number VKM F-3500 D; mutant C1 strain UV13-6, Deposited as Accession Number VKM F-3632 D; mutant C1 strain NG7C-19, Deposited as Accession Number VKM F-3633 D; and mutant C1 strain UV18-25, Deposited as Accession Number VKM F-3631 D.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: DYADIC INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 038241/0496 →
Continuity (8)
Continuation In Part 10394568 · Mar 21, 2003
Continuation In Part 09548938 · Apr 13, 2000
Continuation In Part PCTNL9900618 · Oct 6, 1998
Continuation In Part PCTEP9806496 · Oct 6, 1998
Continuation In Part 12908483
Continuation 09284152 · Jun 3, 1999
Continuation In Part 08731170 · Oct 10, 1998
Related Publication 20110047656A1 · Feb 24, 2011